临床医学工程2024,Vol.31Issue(4) :435-436.DOI:10.3969/j.issn.1674-4659.2024.04.0435

头孢哌酮舒巴坦联合二羟丙茶碱对慢阻肺急性加重期患者症状改善及CAT评分的影响

Impact of Cefoperazone Sulbactam Combined with Diprophylline on Symptom Improvement and CAT Score of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

江远义 高应亮
临床医学工程2024,Vol.31Issue(4) :435-436.DOI:10.3969/j.issn.1674-4659.2024.04.0435

头孢哌酮舒巴坦联合二羟丙茶碱对慢阻肺急性加重期患者症状改善及CAT评分的影响

Impact of Cefoperazone Sulbactam Combined with Diprophylline on Symptom Improvement and CAT Score of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

江远义 1高应亮1
扫码查看

作者信息

  • 1. 江西省上饶市鄱阳县人民医院急诊科,江西上饶 333100
  • 折叠

摘要

目的 探讨头孢哌酮舒巴坦联合二羟丙茶碱治疗慢阻肺急性加重期患者的临床效果.方法 70例慢阻肺急性加重期患者按治疗方法的不同分为两组,对照组给予头孢哌酮舒巴坦治疗,观察组在对照组基础上给予二羟丙茶碱注射液治疗,比较两组的疗效、症状改善时间以及CAT评分.结果 治疗后,观察组的总有效率高于对照组,症状改善时间均短于对照组,CAT评分低于对照组(P<0.05).结论 头孢哌酮舒巴坦联合二羟丙茶碱治疗慢阻肺急性加重期患者的效果显著,可有效改善临床症状.

Abstract

Objective To explore the clinical effect of cefoperazone sulbactam combined with diprophylline in the treatment of patients with acute exacerbation of chronic obstructive pulmonary disease.Methods 70 patients with acute exacerbation of chronic obstructive pulmonary disease were divided into two groups according to different treatment methods.The control group was treated with cefoperazone sulbactam,and the observation group was treated with diprophylline injection on the basis of the control group.The efficacy,symptom improvement time and CAT score were compared between the two groups.Results After treatment,the total effective rate of the observation group was higher than that of the control group,the improvement time of symptoms were shorter than those of the control group,and the CAT score was lower than that of the control group(P<0.05).Conclusions Cefoperazone sulbactam combined with diprophylline in the treatment of patients with acute exacerbation of chronic obstructive pulmonary disease has significant effect,and can effectively improve clinical symptoms.

关键词

慢阻肺急性加重期/头孢哌酮舒巴坦/二羟丙茶碱

Key words

Acute exacerbation of chronic obstructive pulmonary disease/Cefoperazone sulbactam/Diprophylline

引用本文复制引用

出版年

2024
临床医学工程
国家医疗保健器具工程技术研究中心

临床医学工程

影响因子:0.193
ISSN:1674-4659
参考文献量8
段落导航相关论文